Pierre Abramowski

440 total citations
12 papers, 325 citations indexed

About

Pierre Abramowski is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Pierre Abramowski has authored 12 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Pierre Abramowski's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and HIV Research and Treatment (2 papers). Pierre Abramowski is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and HIV Research and Treatment (2 papers). Pierre Abramowski collaborates with scholars based in Germany, Switzerland and United Kingdom. Pierre Abramowski's co-authors include Boris Fehse, Roland Martinꝉ, Jonathan Fisher, John Anderson, Rafał Machowicz, Joachim Hauber, Ulrike Mock, Ilona Hauber, Stefan Horn and Kenth Gustafsson and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cell Reports.

In The Last Decade

Pierre Abramowski

12 papers receiving 321 citations

Peers

Pierre Abramowski
Michael D. Moore United Kingdom
Pinar Ormanoglu United States
King L. Hung United States
Mitchell G. Kluesner United States
Michael Kosicki United States
Tim Beltraminelli Switzerland
Pierre Abramowski
Citations per year, relative to Pierre Abramowski Pierre Abramowski (= 1×) peers Anna Shmakova

Countries citing papers authored by Pierre Abramowski

Since Specialization
Citations

This map shows the geographic impact of Pierre Abramowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Abramowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Abramowski more than expected).

Fields of papers citing papers by Pierre Abramowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Abramowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Abramowski. The network helps show where Pierre Abramowski may publish in the future.

Co-authorship network of co-authors of Pierre Abramowski

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Abramowski. A scholar is included among the top collaborators of Pierre Abramowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Abramowski. Pierre Abramowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Scheuermann, Sophia, et al.. (2025). Targeting CD276 with Adapter-CAR T-cells provides a novel therapeutic strategy in small cell lung cancer and prevents CD276-dependent fratricide. Journal of Hematology & Oncology. 18(1). 76–76. 2 indexed citations
2.
Abramowski, Pierre, et al.. (2024). Identification and Characterization of Fully Human FOLR1-Targeting CAR T Cells for the Treatment of Ovarian Cancer. Cells. 13(22). 1880–1880. 3 indexed citations
3.
Fisher, Jonathan, Roshan Sharma, Marta Barisa, et al.. (2019). Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors. Science Signaling. 12(598). 40 indexed citations
4.
Roh, Vincent, Pierre Abramowski, Kerstin Cornils, et al.. (2018). Cellular Barcoding Identifies Clonal Substitution as a Hallmark of Local Recurrence in a Surgical Model of Head and Neck Squamous Cell Carcinoma. Cell Reports. 25(8). 2208–2222.e7. 29 indexed citations
5.
Fisher, Jonathan, Pierre Abramowski, Barry Flutter, et al.. (2017). Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor. Molecular Therapy. 25(5). 1234–1247. 81 indexed citations
6.
Abramowski, Pierre, Susanne Krasemann, Thomas Ernst, et al.. (2016). Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice. Stem Cells and Development. 25(15). 1134–1148. 19 indexed citations
7.
Abramowski, Pierre, et al.. (2016). Combined Application of RGB Marking and Mass Spectrometric Imaging Facilitates Detection of Tumor Heterogeneity.. PubMed. 12(4). 179–87. 10 indexed citations
8.
Mock, Ulrike, Rafał Machowicz, Ilona Hauber, et al.. (2015). mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Research. 43(11). 5560–5571. 98 indexed citations
9.
10.
Abramowski, Pierre, Benjamin Otto, & Roland Martinꝉ. (2014). The Orally Available, Synthetic Ether Lipid Edelfosine Inhibits T Cell Proliferation and Induces a Type I Interferon Response. PLoS ONE. 9(3). e91970–e91970. 13 indexed citations
11.
Abramowski, Pierre, Karin Steinbach, Axel R. Zander, & Roland Martinꝉ. (2014). Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 274(1-2). 111–124. 9 indexed citations
12.
Abramowski, Pierre, et al.. (2014). A Truncation Variant of the Cation Channel P2RX5 Is Upregulated during T Cell Activation. PLoS ONE. 9(9). e104692–e104692. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026